Chief Business Officer
Pam Carroll brings extensive experience leading drug discovery and business development. She was chief business officer at Silicon Therapeutics prior to its acquisition by Roivant Sciences.
Previously, Pam served as senior vice president of Immuno-oncology at Genocea Biosciences where she spearheaded the company development of vaccines and cell therapies. Prior to Genocea, Pam held the position of vice president at Johnson and Johnson Innovation leading strategic partnerships, new company investments and academic collaborations. She led drug discovery at other organizations, including vice president of Roche Oncology Discovery, head of research at the Belfer Institute for Applied Cancer Sciences at Dana Farber Cancer Center. Earlier in her career, Pam served as director of cancer pathways at Merck Research Laboratories, and senior investigator in applied genomics at Bristol Myers Squibb.
Pam earned a bachelor of science degree in biology from Saint Michael’s College in Colchester, Vt., a doctor of philosophy in cell biology from Stony Brook University in Stony Brook, N.Y. and completed a postdoctoral fellowship at Stanford University in Stanford, Calif.